All In Biotech

Drug Trial Radar · NCT06455059

Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Vosoritide in Children With Hypochondroplasia

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

81

Actual

Start

Jun 17, 2024

Primary completion

Apr 23, 2026

Study completion Apr 23, 2026

Sponsor

Lead sponsor
BioMarin PharmaceuticalBioMarin (BMRN)
Sponsor type
Industry
First posted
Jun 12, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Single group
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 3 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The intent and design of this Phase 3 study is to assess vosoritide as a therapeutic option for the treatment of children with hypochondroplasia (HCH).

Conditions

  • Hypochondroplasia

Interventions

  • VosoritideDrug

    Subcutaneous injection of recommended dose of vosoritide based on weight-band dosing once daily.

  • PlaceboDrug

    Subcutaneous injection of recommended dose of placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in annualized growth velocity (AGV) at Week 52 versus placeboTime frame: At week 52

Locations

23 sites in 9 countries. Site status is shown where the registry gives one.

  • Nemours Alfred I. DuPont Hospital for Children

    Wilmington, Delaware

  • Children's National Medical Center

    Washington D.C., District of Columbia

  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois

  • Medical College of Wisconsin

    Milwaukee, Wisconsin

  • Murdoch Children's Research Institute

    Parkville, Victoria, Australia

  • University of Alberta Stollery Children's Hospital

    Edmonton, Alberta, Canada

  • SickKids - The Hospital for Sick Children

    Toronto, Ontario, Canada

  • Centre Hospitalier Universitaire Sainte-Justine

    Montreal, Quebec, Canada

  • Hospices Civils de Lyon - Hopital Femme Mere Enfant

    Lyon, France

  • Hopital de la Timone

    Marseille, France

  • Hopital Necker-Enfants Malade

    Paris, France

  • CHU de Toulouse

    Toulouse, France

  • Uniklinik Koln

    Cologne, Germany

  • Univeristatskinderklinik Magdeburg

    Magdeburg, Germany

  • Instituto Giannina Gaslini

    Genoa, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Rome, Italy

  • Ospedale Pediatrico Bambino Gesu

    Rome, Italy

  • Osaka University Hosptial

    Osaka, Japan

  • Tokushima University Hospital

    Tokushima, Japan

  • Institute of Science Tokyo Hospital

    Tokyo, Japan

  • Tottori University Hospital

    Tottori, Japan

  • Vithas Hospital San Jose

    Vitoria-Gasteiz, Spain

  • Great Ormond Street Hospital for Children NHS Foundation Trust

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.